# Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery

> **NCT00201214** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 26 (actual)

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Heart Defects, Congenital

## Interventions

- **DRUG:** Citrulline

## Key facts

- **NCT ID:** NCT00201214
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2006-01
- **Final completion:** 2009-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201214, "Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00201214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*